LobbyingBluestem Biosciences lobbying by quarter
Bluestem Biosciences's latest lobbying report covers Q2 2026, at under $5,000. Its first report covers Q1 2024; the issues it reports most are Agriculture and Chemicals/Chemical Industry.
Bluestem Biosciences
- Latest quarter
- $0
- Q2 2026 · 1 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q2 2026 against the quarter before
- First report
- Q1 2024
- The first quarter a report named it
Lobbying by quarter
No lobbying spend in this period.
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2024 | $0 | 1 |
| Q2 2024 | $0 | 1 |
| Q3 2024 | $0 | 1 |
| Q4 2024 | $0 | 1 |
| Q1 2025 | $0 | 1 |
| Q2 2025 | $0 | 1 |
| Q3 2025 | $0 | 1 |
| Q4 2025 | $0 | 1 |
| Q1 2026 | $0 | 1 |
| Q2 2026 | $0 | 1 |
Policy issues the reports name
- Agriculture10 reports
- Chemicals10 reports
- Energy and nuclear8 reports
A report that names several issues counts once for each.
Who was lobbied
- Energy, Dept of10 reports
- HOUSE OF REPRESENTATIVES10 reports
- SENATE10 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseBluestem Biosciences | $0 | 10 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/10for Q2 | In-house | Under $5,000 |
| 04/28for Q1 | In-house | Under $5,000 |
| 02/12for Q4 2025 | In-house | Under $5,000 |
| 25/11/10for Q3 2025 | In-house | Under $5,000 |
| 25/08/21for Q2 2025 | In-house | Under $5,000 |
| 25/05/06for Q1 2025 | In-house | Under $5,000 |
| 25/01/27for Q4 2024 | In-house | Under $5,000 |
| 24/11/07for Q3 2024 | In-house | Under $5,000 |
| 24/07/11for Q2 2024 | In-house | Under $5,000 |
| 24/05/07for Q1 2024 | In-house | Under $5,000 |
| 24/05/06for Q1 2024 | In-house | Under $5,000 |